Navigation Links
CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA
Date:12/10/2007

/p>

About Peripheral T-cell Lymphoma

Peripheral T-cell lymphoma (PTCL) is a type of non-Hodgkin's Lymphoma (NHL) which arises from malignant T-lymphocytes, also known as T-cells, and account for approximately 15%, or more than 5,000 cases, of all NHL cases diagnosed in the U.S. PTCL tends to be an aggressive form of NHL with a five-year survival of less than 30%. There are currently no FDA approved drugs for the treatment of PTCL.

About Belinostat

Belinostat is a small molecule histone deactylase (HDAC) inhibitor being investigated for its role in the treatment of a wide range of solid tumors and hematologic malignancies as a single-agent and in combination with other active anti-cancer agents, including carboplatin, paclitaxel, cis-retinoic acid, azacitidine, idarubicin and bortezomib. HDAC inhibitors represent a new mechanistic class of anti-cancer therapeutics that target HDAC enzymes and have been shown to arrest growth of cancer cells (including drug resistant subtypes); induce apoptosis, or programmed cell death; promote differentiation; inhibit angiogenesis; and sensitize cancer cells to overcome drug resistance when used in combination with other anti-cancer agents.

Intravenous belinostat is currently being evaluated in multiple clinical trials as a potential treatment for cutaneous and peripheral T-cell lymphomas, B-cell lymphomas, AML, mesothelioma, soft tissue sarcoma, myelodysplastic syndrome, and liver, colorectal, and ovarian cancers, either alone or in combination with other anti-cancer therapies. An oral formulation of belinostat is also being evaluated in a Phase I clinical trial for patients with advanced solid tumors. In August 2004, CuraGen signed a Clinical Trials Agreement with the NCI under which the NCI will sponsor several clinical trials to investigate belinostat for the treatment of various cancers, both as a single-agent and in combination chemotherapy regimens. In May 2005, TopoTarget announced the signing o
'/>"/>

SOURCE CuraGen Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. CuraGen to Present at the Bear Stearns 20th Annual Healthcare Conference
2. CuraGen Reports Third Quarter 2007 Financial Results
3. Virginia Tech Report Has National Importance
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. GAO Report Confirms: Medicare Underpays for Anesthesia Services; Nurse Anesthetists Assure Seniors Access to Safe Anesthesia Care
6. Haemacure Reports Third Quarter 2007 Results
7. Report on patients access to cancer drugs uses flawed methods to reached flawed conclusions
8. Biotech Finishes on a High in August, Burrill Report Says
9. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
10. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
11. MDS Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Denver, CO (PRWEB) July 29, 2014 ... review that this actually is a new method of ... , The author of the new method ensure sufferers ... undergo the right recommendations. , The new method ... help sufferers completely overcome sciatica with an 8 minutes ...
(Date:7/29/2014)... Winter is here down under, and ... Sydney’s central business district. That is, until a troop ... the otherwise ordinary day into a celebration—a celebration of ... advocates of The Truth About Drugs, a drug prevention ... They woke up the city with a rousing performance ...
(Date:7/29/2014)... Australia (PRWEB) July 30, 2014 ... of medical devices have determined Nurse Call Systems ... international legislation, this requires all Nurse Call Systems ... regulatory practice improves patient safety, reduces clinical risks, ... private hospital based Corporate Risk and Clinical Risk ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Daily Gossip writes ... powerful and holistic system that will teach users how to ... by thousands of people, from all over the world. ... symptoms of this disorder in as quickly as 12 hours. ... gone faster than imagined. , The Fibroids Miracle review ...
(Date:7/29/2014)... 29, 2014 Regardless of the good ... special someone to share those with. Love is about ... , Love is also about overcoming all the ... have that perfect relationship, women need to know how ... the Enchant Him program, please visit the official website ...
Breaking Medicine News(10 mins):Health News:Stop Sciatica in 8 Minutes Review Reveals the Way to Cure Sciatica Easily 2Health News:Sydney Business District “Rocked” by The Truth About Drugs 2Health News:NiQ Health Reveals the Extensive Use of Unregulated Medical Devices in Australian Hospitals 2Health News:NiQ Health Reveals the Extensive Use of Unregulated Medical Devices in Australian Hospitals 3Health News:NiQ Health Reveals the Extensive Use of Unregulated Medical Devices in Australian Hospitals 4Health News:Amanda Leto’s Fibroids Miracle Review Reveals Clinically Proven Uterine Fibroids Cure System 2Health News:How to Reach the Heart of the Perfect Guy with "Enchant Him Program" - a Report by Daily Gossip Magazine 2
... the world. It can lead to strokes, heart attacks and ... half an hour and an hour of moderate exercise on ... heart disease, cancer, diabetes and obesity.,Researchers from Japan, tested 207 ... otherwise healthy. None exercised regularly. ,They divided them into ...
... before it's in a more advanced stage is key to ... early lung cancer, researchers wanted to determine if it is ... wanted to look at the cost-effectiveness of a CT scan ... the Early Lung Cancer Action Project (ELCAP) that was conducted ...
... significantly improve memory.,New research shows a centuries-old herbal remedy ... ,A team of researchers tested 44 healthy, young ... sage oil capsules, and some were given placebos. In ... oil performed significantly better than those who didn't. ...
... crippling as depression can be for young and middle-age ... often fatal.// And while depression and related illnesses afflict ... getting the treatment they need. ,"Depression kills not ... research at the National Institute of Mental Health. "[Elderly] ...
... American and German researchers say they've developed a new ... // ,They've developed a radio-isotope that emits far more ... metastases that are formed when tumor cells invade bone ... control bone pain in people with bone metastases. ...
... new study shows the best time to make a prognosis ... Researchers find cell counts //at that time give a more ... originally diagnosed with HIV. ,Highly active antiretroviral therapy (HAART) ... the prognosis of HIV patients, however there is not a ...
Cached Medicine News:
(Date:7/29/2014)...  Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... conferences during the third quarter, the 2014 Avondale Partners ... 2014 Conference.  Alexza,s corporate presentation will be webcast live ... event are below: , 2014 Avondale Partners ... Boston , MA.  The format is limited ...
(Date:7/29/2014)... ROCKVILLE, Md. , July 29, 2014  Synthetic ... anti-infective biologic and drug candidates targeting specific pathogens that ... view of the unusual market activity in the Company,s ... Company in accordance with its usual practice. The Company ... unusual market activity. About Synthetic Biologics, Inc. ...
(Date:7/29/2014)... Conn. , July 29, 2014 Numotion,s Board ... Mike Swinford will be the company,s new Chief ... highly successful 22-year career at GE where he worked primarily ... in annual revenue to over $5 billion. His most recent ... Services. "I am thrilled to join Numotion," ...
Breaking Medicine Technology:Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 2Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 3Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2Numotion Names Mike Swinford CEO 2
... DrDrugs®: Drug Guide for ... over 760 Integrated Calculators ... comprehensive, up-to-date and practical ... in drug dosing calculation ...
DRUGology is a source designed for primary care health providers, residents and medical students so that they may have a quick reference to treat a wide variety of conditions....
AnesthesiaDrugs™ is the handheld version of Sota Omoigui's Anesthesia Drugs Handbook, the best selling clinical guide to essential anesthesia and critical care drug information....
... extensive evidence-based data than any other drug reference., ... as it's come to be known, has gone ... seeking answers to the most detailed questions. It ... drug reference and is now available for your ...
Medicine Products: